Assessing Cost-Effectiveness in Obesity (ACE-Obesity): an overview of the ACE approach, economic methods and cost results

被引:90
|
作者
Carter, Rob [1 ]
Moodie, Marj [1 ]
Markwick, Alison [2 ]
Magnus, Anne [1 ]
Vos, Theo [3 ]
Swinburn, Boyd [4 ]
Haby, Michele M. [2 ]
机构
[1] Deakin Univ, Publ Hlth Res Evaluat & Policy Cluster, Burwood, Vic 3125, Australia
[2] Dept Human Serv, Publ Hlth Branch, Melbourne, Vic 3000, Australia
[3] Univ Queensland, Sch Populat Hlth, Ctr Burden Dis & Cost Effectiveness, Herston, Qld 4006, Australia
[4] Deakin Univ, WHO Collaborating Ctr Obes Prevent, Melbourne, Vic 3125, Australia
关键词
MENTAL-HEALTH; INTERVENTIONS; CHILDREN;
D O I
10.1186/1471-2458-9-419
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: The aim of the ACE-Obesity study was to determine the economic credentials of interventions which aim to prevent unhealthy weight gain in children and adolescents. We have reported elsewhere on the modelled effectiveness of 13 obesity prevention interventions in children. In this paper, we report on the cost results and associated methods together with the innovative approach to priority setting that underpins the ACE-Obesity study. Methods: The Assessing Cost Effectiveness ( ACE) approach combines technical rigour with 'due process' to facilitate evidence-based policy analysis. Technical rigour was achieved through use of standardised evaluation methods, a research team that assembles best available evidence and extensive uncertainty analysis. Cost estimates were based on pathway analysis, with resource usage estimated for the interventions and their 'current practice' comparator, as well as associated cost offsets. Due process was achieved through involvement of stakeholders, consensus decisions informed by briefing papers and 2(nd) stage filter analysis that captures broader factors that influence policy judgements in addition to cost-effectiveness results. The 2(nd) stage filters agreed by stakeholders were 'equity', 'strength of the evidence', 'feasibility of implementation', 'acceptability to stakeholders', 'sustainability' and 'potential for side-effects'. Results: The intervention costs varied considerably, both in absolute terms (from cost saving [6 interventions] to in excess of AUD50m per annum) and when expressed as a 'cost per child' estimate (from < AUD1.0 [reduction of TV advertising of high fat foods/high sugar drinks] to AUD31,553 [laparoscopic adjustable gastric banding for morbidly obese adolescents]). High costs per child reflected cost structure, target population and/or under-utilisation. Conclusion: The use of consistent methods enables valid comparison of potential intervention costs and cost-offsets for each of the interventions. ACE-Obesity informs policy-makers about cost-effectiveness, health impact, affordability and 2nd stage filters for important options for preventing unhealthy weight gain in children. In related articles cost-effectiveness results and second stage filter considerations for each intervention assessed will be presented and analysed.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] The cost-effectiveness of pharmacotherapy and lifestyle intervention in the treatment of obesity
    Lee, Minyi
    Lauren, Brianna N.
    Zhan, Tiannan
    Choi, Jin
    Klebanoff, Matthew
    Abu Dayyeh, Barham
    Taveras, Elsie M.
    Corey, Kathleen
    Kaplan, Lee
    Hur, Chin
    OBESITY SCIENCE & PRACTICE, 2020, 6 (02): : 162 - 170
  • [22] Cost-Effectiveness Analysis of Bariatric Surgery for Morbid Obesity
    Adnan Alsumali
    Tewodros Eguale
    Sigrid Bairdain
    Mihail Samnaliev
    Obesity Surgery, 2018, 28 : 2203 - 2214
  • [23] COST-EFFECTIVENESS OF BARIATRIC SURGERY FOR THE TREATMENT OF OBESITY IN AUSTRALIA
    Salton, R.
    VALUE IN HEALTH, 2015, 18 (07) : A671 - A671
  • [24] Cost-Effectiveness of Antiobesity Drugs for Adolescents With Severe Obesity
    Mital, Shweta
    Nguyen, Hai V.
    JAMA NETWORK OPEN, 2023, 6 (10) : E2336400
  • [25] COST-EFFECTIVENESS ANALYSIS OF LIRAGLUTIDE FOR THE TREATMENT OF OBESITY IN MEXICO
    Valdez-Huerta, R.
    Moreno, D.
    Paladio Hernandez, J. A.
    VALUE IN HEALTH, 2022, 25 (07) : S350 - S350
  • [26] Cost-Effectiveness of Semaglutide in Patients With Obesity and Cardiovascular Disease
    Rennert-May, Elissa
    Manns, Braden
    Clement, Fiona
    Spackman, Eldon
    Collister, David
    Sumner, Glen
    Leal, Jenine
    Miller, Robert J. H.
    Chew, Derek S.
    CANADIAN JOURNAL OF CARDIOLOGY, 2025, 41 (01) : 128 - 136
  • [27] COST-EFFECTIVENESS OF BARIATRIC SURGERIES TO REDUCE OBESITY IN EGYPT
    Fasseeh, A.
    El-Fass, K.
    Seyam, A.
    Maher, N.
    Abdelaziz, R.
    Nagy, B.
    VALUE IN HEALTH, 2024, 27 (12) : S88 - S89
  • [28] Cost-effectiveness of a primary care intervention to treat obesity
    Tsai, A. G.
    Wadden, T. A.
    Volger, S.
    Sarwer, D. B.
    Vetter, M.
    Kumanyika, S.
    Berkowitz, R. I.
    Diewald, L. K.
    Perez, J.
    Lavenberg, J.
    Panigrahi, E. R.
    Glick, H. A.
    INTERNATIONAL JOURNAL OF OBESITY, 2013, 37 : S31 - S37
  • [29] Cost-Effectiveness Analysis of Bariatric Surgery for Morbid Obesity
    Alsumali, Adnan
    Eguale, Tewodros
    Bairdain, Sigrid
    Samnaliev, Mihail
    OBESITY SURGERY, 2018, 28 (08) : 2203 - 2214
  • [30] Cost-effectiveness of Family-Based Obesity Treatment
    Quattrin, Teresa
    Cao, Ying
    Paluch, Rocco A.
    Roemmich, James N.
    Ecker, Michelle A.
    Epstein, Leonard H.
    PEDIATRICS, 2017, 140 (03)